Gurumaa Cares & Cures Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.28 M
as on 24-10-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.50 M
as on 24-10-2024
- Revenue 87.54%
(FY 2023)
- Profit 216.97%
(FY 2023)
- Ebitda 498.42%
(FY 2023)
- Net Worth 9.79%
(FY 2023)
- Total Assets 18.26%
(FY 2023)
About Gurumaa Cares & Cures
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.28 M.
The company has closed loans amounting to ₹0.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ganesh Kadam, Droupadi Kadam, Lokesh Patade, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85190MH2012PTC235147
- Company No.
235147
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Gurumaa Cares & Cures?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranav Kadam  | Director | 06-Mar-2017 | Current |
| Ganesh Kadam | Director | 30-Aug-2012 | Current |
| Droupadi Kadam | Director | 30-Aug-2012 | Current |
| Lokesh Patade | Additional Director | Current | |
| Priyanka Patade | Additional Director | 02-Jun-2022 | Current |
Financial of Gurumaa Cares & Cures.
Gurumaa Cares & Cures Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 87.54% increase. The company also saw a substantial improvement in profitability, with a 216.97% increase in profit. The company's net worth moved up by a moderate rise of 9.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gurumaa Cares & Cures?
In 2023, Gurumaa Cares & Cures had a promoter holding of 94.55% and a public holding of 5.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Bharat Co-Operative Bank (Mumbai) Ltd Creation Date: 25 Apr 2015 | ₹0.50 M | Satisfied |
How Many Employees Work at Gurumaa Cares & Cures?
Unlock and access historical data on people associated with Gurumaa Cares & Cures, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gurumaa Cares & Cures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gurumaa Cares & Cures's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
